final os from netter-1: lutetium-177-dotatate in patients with midgut nets
Published 3 years ago • 680 plays • Length 4:25Download video MP4
Download video MP3
Similar videos
-
1:59
netter-1 update: 177lu-dotatate in patients with midgut neuroendocrine tumors
-
1:57
177lu-dotatate in patients with well-differentiated, high-grade nets
-
1:36
dr. strosberg on netter-1 trial results for midgut nets
-
2:03
dr. strosberg on the results of the netter-1 trial
-
23:34
netter 1 phase iii in patients with midgut neuroendocrine tumors treated with 177lu dotatate efficac
-
1:41
dr. jonathan r. strosberg on 177-lu-dotatate in patients with neuroendocrine tumors
-
1:19
dr. strosberg on future of 177lu-dotatate therapy in neuroendocrine tumors
-
2:58
netter-1: radioactive octreotide effective in metastatic neuroendocrine tumors
-
6:49
guilmant - sonata no. 1 d minor op. 42 / final
-
4:51
uni-t ut61e multimeter repair [1/4]
-
40:05
uni-t pro ut195e multimeter review teardown!
-
3:09
new treatment for neuroendocrine tumors
-
2:13
understanding neuroendocrine tumors
-
2:12
what is lutetium 177? | mercy radiology
-
10:28
anzup therap study (lu-177 psma-617 vs. cabazitaxel): overall survival after 3 years follow-up
-
49:49
netwise episode 17: focus on liver nets
-
22:53
functional v. nonfunctional net symptoms, heloisa soares, md, phd
-
7:00
treating metastases associated with neuroendocrine tumors (nets)
-
5:14
accurately diagnosing nets
-
2:16
dr. strosberg on quality of life for midgut neuroendocrine tumors
-
10:23
panel: surgery for neuroendocrine tumors: disease-specific issues and opportunities
-
16:55
pathological classification of net